![FDA has cleared Prime Medicine’s PM359 for the treatment of chronic granulomatous disease](https://oncodaily.com/pub/uploads/2024/04/Screenshot-13-e1714485043401-1280x669.png)
Photo from Prime Medicine/X
May 1, 2024, 12:12
FDA has cleared Prime Medicine’s PM359 for the treatment of chronic granulomatous disease
Prime Medicine shared on X/Twitter:
“We are pleased to announce that FDA has cleared our IND application for PM359 for the treatment of chronic granulomatous disease (CGD), enabling Prime to initiate its Phase 1/2 clinical trial in the US. Details.”
Source: Prime Medicine/X